Navigation Links
Vitrasert Sterile Intraviteral Implant

ProductsVitrasert Sterile Intraviteral Implant
Company Bausch & Lomb Storz
Item Vitrasert Sterile Intraviteral Implant
Features The Vitrasert implant contains ganciclovir embedded in a polymer-based system that slowly releases the drug. The implant, surgically placed in the posterior segment of the eye, allows diffusion of the drug locally to the site of infection over an extended period of months. Implantation normally takes less than one hour, requires only local anesthesia, and is conducted in an outpatient, day-surgery setting. Immediately following insertion of the implant, most patients experience transient blurred vision in the operated eye, which generally clears within two to four weeks. The implant can be removed when depleted of drugs, usually within five to eight months, and a new Vitrasert implant can be inserted.
Description Vitrasert implant is a device that delivers ganciclovir intraocularly in patients with Aids-related Cytomegalovirus (CMV) Retinitis. This approach can significantly delay progression of CMV when compared with conventional intravenous treatment. The Vitrasert implant contains ganciclovir embedded in a polymer-based system that slowly releases the drug. The implant, surgically placed in the posterior segment of the eye, allows diffusion of the drug locally to the site of infection over an extended period of months.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000

Related medicine products :

1. Sterile Blades
2. Sterile Cordless Eraser Tips
3. Sensitive Eyes Sterile Saline Spray
4. Sterile Preserved Saline Solution
5. Lens Plus Sterile Saline Solution
6. Sterile Preserved Daily Cleaner
7. Non-Sterile Oncoseed (Iodine-125 Seeds)
8. Oncoseed Sterile Convenience Pack (Iodine-125 Seeds)
9. Balanced Salt Solution (Sterile Irrigating Solution)
10. Hoffmann Classic Sterile Wrist Kit
11. Biotrace Sterile Barium Sulfate USP
Enzymatic Clearance assay for the in vitro quantitative determination of LDL-cholesterol in human serum and plasma....
Enzymatic Clearance assay for the in vitro quantitative determination of LDL-cholesterol in human serum and plasma....
For the quantitative in vitro determination of Ammonia in plasma...
Enzymatic assay for the quantitative in vitro determination of glycated protein (fructosamine) in human serum or plasma....
Medicine Products:
(Date:3/28/2017)... , ... March 28, 2017 , ... ... by physicians, announced today the launch of a free, public-facing tool for analyzing ... Analyzer (VCA) was developed to provide comparative information to patients, providers, insurers and ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Radiology Business Management Association (RBMA) ... as its new executive director. Mr. Still was selected through a careful months-long search ... as he is known to our members, has been a part of building the ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... ... With expansion and efficiency in mind, Patten Seed Company completed relocation of ... opened in Marshallville in 2006, and a bagging and shipping facility has been in ... Patten Seed operations to the Middle Georgia location from their previous home in Lakeland, ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... FRANCISCO , March 28, 2017 ...  is expected to reach a value of USD 4.5 ... Grand View Research, Inc. Proper closure of injured tissues ... structure and function. Postoperative leakages occur in 3% to ... complication. They are responsible for one third of postoperative ...
(Date:3/27/2017)... The National University of Singapore (NUS) ... company, signed a Memorandum of Understanding (MOU) recently ... the region. Under this MOU, ... Technology (BIGHEART) at NUS and Holmusk will establish ... healthcare IT and medical device development. These include ...
(Date:3/27/2017)... WAUKESHA, Wis. , March 27, 2017  A ... one of only four freestanding hospitals in the country ... in plastic and reconstructive surgery, concluded that the Surfacide ... effective and integral component in reducing bacterial pathogens not ... The findings were published at the American Burn Association,s ...
Breaking Medicine Technology: